title: Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Fasano
authors.forename: Alessandro
authors.initials: A
authors.lastname: Di Matteo
authors.forename: Carmine
authors.initials: C
authors.lastname: Vitale
authors.forename: Giovanna
authors.initials: G
authors.lastname: Squintani
authors.forename: Laura
authors.initials: L
authors.lastname: Ferigo
authors.forename: Federica
authors.initials: F
authors.lastname: Bombieri
authors.forename: Gabriella
authors.initials: G
authors.lastname: Santangelo
authors.forename: Marianna
authors.initials: M
authors.lastname: Amboni
authors.forename: Paolo
authors.initials: P
authors.lastname: Barone
authors.forename: Michele
authors.initials: M
authors.lastname: Tinazzi
mesh_terms: D000368:Aged; D015259:Dopamine Agents / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D004421:Dystonia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007189:Indans / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000009:adverse effects; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D015259:Dopamine Agents; D007189:Indans; D018696:Neuroprotective Agents; C031967:rasagiline